Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Кафедра психиатрии и наркологии лечебного факультета ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России
Список исп. литературыСкрыть список 1. Игнатова Т.М. Хронический гепатит С: клинико-морфологическая характеристика, течение, лечение. Автореф. дис. … д-ра мед. наук. М., 2000. 2. Sockalingam S, Abbey SE. Managing depression during hepatitis C treatment. Can J Psychiatry 2009; 54 (9): 614–25. 3. Crone C, Gabriel GM, Wise TN. Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C. Cleve Clin J Med 2004; 71 (Suppl. 3): 27–32. 4. Pavlović Z, Delić D, Marić NP et al. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study. Psychiatr Danub 2011; 23 (4): 370–7. 5. Shakoor A, Shafqat F, Mehmud T et al. Frequency of depression and somatic symptoms in patients on interferon alpha/ribavirin for chronic hepatitis C. J Ayub Med Coll Abbottabad 2010; 22 (4): 6–9. 6. Gohier B, Goeb JL, Rannou-Dubas K et al. Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients. World J Biol Psychiatry 2003; 4 (3): 115–8. 7. Nickel T, Sonntag A, Backmund M et al. Depression during therapy with interferon alpha – how long should antidepressant treatment last? Pharmacopsichiatry 2005; 38 (2): 102–4. 8. Robaeys G, Buntinx F. Treatment of hepatitis C viral infections in substance abusers. Acta Gastroenterol Belg 2005; 68 (1): 55–67. 9. Holtzheimer PE, Veitengruber J, Wang CC et al. Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment. Gen Hosp Psychiatry 2010; 32 (4): 426–32.